Skip to main content
main-content

Welcome

We provide news, expert interviews, and educational resources to help you keep up with the latest developments in rheumatology

Have the ORAL Surveillance results changed rheumatology practice?

Following publication of the ORAL Surveillance trial, Richard Conway and Kevin Winthrop discuss the impact of the findings on JAK inhibitor prescribing, how regulatory recommendations compare in Europe and the USA, and whether the risks seen with tofacitinib represent a class effect.

New additions to the Adis Journal Club – August update

Browse August's selection of peer-reviewed articles from the Adis journal portfolio. Curated by the editors and updated monthly. These papers highlight topical research and reviews for the benefit of Medicine Matters readers.

News

TNF inhibitor use during pregnancy linked to higher infant birthweight

Tumor necrosis factor inhibitor use by pregnant women with well-controlled rheumatoid arthritis is associated with a reduced risk for having a child that is born small for gestational age, study findings indicate.

New additions to the Adis Journal Club

A monthly selection of topical peer-reviewed articles from the Adis journals, curated by the editors.

IN FOCUS | JAK inhibitors

Richard Conway and Kevin Winthrop

05-08-2022 | JAK inhibitors | Video

Have the ORAL Surveillance results changed rheumatology practice?

Following publication of the ORAL Surveillance trial, Richard Conway and Kevin Winthrop discuss the impact of the findings on JAK inhibitor prescribing, how regulatory recommendations compare in Europe and the USA, and whether the risks seen with tofacitinib represent a class effect.

JAK inhibitor safety

Data summary, expert discussion, & research news on the potential risks associated with JAK inhibitors.

IN FOCUS | COVID-19 & rheumatic disease

Antibodies, immunoglobulin proteins, Immune system. 3D rendering

30-06-2022 | COVID-19 | News

VROOM trial: Pausing methotrexate doubles antibody response to COVID-19 booster vaccine

Holding methotrexate treatment for 2 weeks following administration of a booster dose of vaccines against SARS-CoV-2 significantly improves the humoral immune response to vaccination, suggest findings from a randomized controlled trial.

Rituximab and rheumatology practice in the COVID-19 era

How can rheumatologists respond to the challenges associated with rituximab use during the pandemic?

IN FOCUS | Inflammatory arthritis

Mid section of pregnant woman standing in corridor of hospital (symbolic image with model)

28-07-2022 | Rheumatoid arthritis | News

TNF inhibitor use during pregnancy linked to higher infant birthweight

Tumor necrosis factor inhibitor use by pregnant women with well-controlled rheumatoid arthritis is associated with a reduced risk for having a child that is born small for gestational age, study findings indicate.

Common scores used in rheumatology

An at-a-glance reference guide to the scores that are commonly used in clinical trials & daily rheumatology practice

IN FOCUS | Gout and crystal arthropathies

Kidneys

25-01-2022 | Gout | News

​​​​​​​Allopurinol use not linked to increased mortality risk in people with gout, CKD

Individuals with gout and concurrent chronic kidney disease are no more likely to die following allopurinol initiation, dose escalation, or achievement of target serum urate levels than those not taking the drug, study findings indicate.

Febuxostat and cardiovascular risk in people with gout

How will the FAST trial results impact regulatory guidance & clinical practice?

IN FOCUS | Lupus

Coronary artery plaque

17-05-2022 | Systemic lupus erythematosus | News

Vascular plaque burden could predict future CVD risk in people with SLE

The overall burden of vascular plaque measured on ultrasound scans is significantly associated with future risk for cardiovascular disease events in people with systemic lupus erythematosus, study findings indicate.

Anifrolumab for the treatment of lupus

Perspective on the approval of anifrolumab and the importance of endpoints in lupus trials.

Stay informed with Medicine Matters

Get the latest developments in rheumatology delivered straight to your inbox

Podcasts

Interviews with expert rheumatologists on patient care